In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Redwood Bioscience Inc.

Division of Catalent Inc.

Latest From Redwood Bioscience Inc.

The Benevolent Investor: Institutional Ventures Grow In Size And Reach

A growing number of medical research institutions are investing in start-ups as a venture capitalist would, at times in new companies that have only tangential ties to the home institution.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, November 2014

BioPharmaceutical Medical Device

Antibody-Drug Conjugates: The Next Generation Of Moving Parts

The next generation of antibody-drug conjugates have much room for improvement: engineered proteins, drugs, the linkers that bond them together, and perhaps even new targets to attack. All their complexity is an invitation to innovation, but will the parts come together into products that prove safe and efficacious in the clinic?

BioPharmaceutical Strategy

On The Move

See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Catalent Inc.
  • Senior Management
  • Karen Boezi, CEO
    David Rabuka, PhD, CSO
  • Contact Info
  • Redwood Bioscience Inc.
    Phone: (510) 343-6031
    5703 Hollis St.
    Emeryville, CA 94608